CABENUVA
Google image searchProduct monograph
Active ingredients
cabotegravir, 200 MG/ML
rilpivirine, 300 MG/ML
DIN: 02497220
Dosage form(s): SUSPENSION (EXTENDED-RELEASE), KIT
Route(s) of administration: INTRAMUSCULAR
Description: KIT CONTAINS 2 ML VIAL OF CABOTEGRAVIR AND 2 ML VIAL OF RILPIVIRINE
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 21-SEP-2020
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
